Aprameya Engineering Ltd, a leading player in healthcare infrastructure, has seen a remarkable response to its initial public offering (IPO), which opened for subscription on July 25 and will close on July 29. The IPO has been priced within a range of ₹56 to ₹58 per share, with a face value of ₹10 per share. Investors can bid for a minimum of 2,000 shares, making the minimum investment around ₹1.16 lakh at the upper price band.
The IPO allocation is structured with 50% of the net issue reserved for Qualified Institutional Buyers (QIBs), 35% for retail investors, and 15% for Non-Institutional Investors (NIIs). High-net-worth individuals (HNIs) looking to invest will need to apply for a minimum of two lots, totaling 4,000 shares, which equates to an investment of approximately ₹2.32 lakh.
Founded in September 2003, Aprameya Engineering has carved a niche in the Indian healthcare sector by providing high-quality medical equipment and infrastructure. The company specializes in the installation, configuration, and maintenance of critical healthcare facilities, including operating rooms, intensive care units (ICUs), neonatal ICUs, pediatric ICUs, and prefabricated structural wards.
Over the past few years, Aprameya Engineering has demonstrated significant growth, generating approximately ₹235 crore in revenue from its hospital infrastructure projects between FY21 and FY24. The company has successfully constructed over 2,000 Critical Care beds since 2020, catering to a diverse clientele that includes renowned medical professionals, diagnostic centers, and both government and private hospitals across India.
In FY-23, Aprameya Engineering was responsible for the construction, building, and commissioning of 175 dialysis units at government hospitals in Rajasthan, with a project value of ₹31.43 crore. The company’s focus on healthcare infrastructure has proven lucrative, with 71% of its income in the fiscal year 2024 derived from this sector. The company reported operating margins of 10.07% EBITDA and 5.30% PAT, translating to an annual revenue of ₹65.62 crore.
As of the first day of bidding, the Aprameya Engineering IPO has been oversubscribed by 3.28 times, indicating strong interest from investors. The retail portion has been subscribed 1.72 times, while the NII segment has seen a subscription rate of 1.33 times. Most notably, the QIB portion has been heavily oversubscribed, with bids received for 7.49 times the available shares.
In total, the company has received bids for 1,10,10,000 shares against the 33,52,000 shares on offer, showcasing robust demand from various investor segments. The successful launch of this IPO not only highlights the confidence investors have in Aprameya Engineering’s business model but also reflects the growing importance of healthcare infrastructure in India.
Investors keen on participating in the IPO should keep an eye on the subscription status as the bidding period progresses. With a unique position in the market and a strong track record in healthcare projects, Aprameya Engineering is set to make a significant impact in the public domain.
